The phrase "application to individuals" is correct and usable in written English.
It can be used in contexts where you are discussing how a certain rule, policy, or concept applies specifically to people rather than organizations or groups.
Example: "The new policy has a specific application to individuals who work remotely, ensuring they receive the same benefits as in-office employees."
Alternatives: "relevance to individuals" or "pertinence to individuals".
Perhaps the principles of justice in their application to individuals take a somewhat different form than they do in their application to institutions.
Note also that by including interaction terms of the type (a j ⋅ Z i ), marginal utility and hence the marginal rate of substitution can be made to depend on an individual characteristic (for an application to individuals with and without chronic conditions, see e.g. Mc Neil Vroomen & Zweifel 2011 [4]).
However, neuropsychological models of ADHD are child-based and have yet to undergo extensive empirical scrutiny with respect to their application to individuals with persistent symptoms in adulthood.
Nonetheless, neuropsychological models of ADHD are child-based and have yet to undergo extensive empirical scrutiny with respect to their application to individuals with persistent symptoms in adulthood.
In addition, the DRIs and ULs are based on the healthy population and their application to individuals with a clinical diagnosis is not known.
The UK is likely to have proportionately more PAS deaths than Oregon due to the bill's wider application to individuals with more severe physical disabilities.
Finally, Edwards' emphasis on the objective side of God's act of redemption is comparatively rare in a Puritanism which tended to stress the redemption's application to individual souls.
To analyse and provide the tools to answer three questions that must be asked about a clinical trial on treatments: evaluation of validity (internal validity, so that results are not biased); clinical importance of these results and their application to individual patients.
At the moment, these issues are practically related to acquisition of data for research, but actual clinical application to individual patient care is already beginning.
Here, we describe the CPMC PhAESIS system, designed to guide the development of the CPMC drug PGx risk reports, and its application to individual drug-gene pairs.
While useful at a global level, the lack of specificity of this approach may ultimately limit its application to individual patients because without linking risk to etiology, assessment does not indicate an intervention.
